Last week, the FDA approved an expanded indication for single-sided deafness and asymmetric hearing loss for MED-EL's Synchrony cochlear implant device, opening up the potential for millions of new patients to access the technology to improve their hearing health.
Cochlear Ltd., an Australian company specializing in implants and other devices for people with hearing loss, has developed a product used in a space shared by clinicians, health IT professionals and high-tech audio wizards.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
For many severely hearing impaired or deaf people, cochlear implants have made a huge impact, but they require surgery and can cost up to $100,000. Scientists at Colorado State University have a new, unusual and far less expensive solution that could allow people to essentially hear using their tongue. IFLScience explained the device: A Bluetooth-enabled […]